The ClinGen Evidence Repository is an FDA-recognized human genetic variant database containing expert-curated assertions regarding variants' pathogenicity and supporting evidence summaries. [Disclaimer]
  • No CSPEC related information was provided by the message!

  • See Evidence submitted by expert panel for details.

Variant: NM_000018.4(ACADVL):c.881_884dup (p.Pro296fs)

CA8337899

371464 (ClinVar)

Gene: ACADVL
Condition: very long chain acyl-CoA dehydrogenase deficiency
Inheritance Mode: Autosomal recessive inheritance
UUID: 44973038-39f3-43ad-a2ba-60375c1105bc

HGVS expressions

NM_000018.4:c.881_884dup
NM_000018.4(ACADVL):c.881_884dup (p.Pro296fs)
NC_000017.11:g.7222669_7222672dup
CM000679.2:g.7222669_7222672dup
NC_000017.10:g.7125988_7125991dup
CM000679.1:g.7125988_7125991dup
NC_000017.9:g.7066712_7066715dup
NG_007975.1:g.7836_7839dup
NG_008391.2:g.2379_2382dup
ENST00000356839.10:c.881_884dup
ENST00000322910.9:c.*836_*839dup
ENST00000350303.9:c.815_818dup
ENST00000356839.9:c.881_884dup
ENST00000543245.6:c.950_953dup
ENST00000578824.5:n.30_33dup
ENST00000581378.5:n.599_602dup
ENST00000582379.1:n.265_268dup
NM_000018.3:c.881_884dup
NM_001033859.2:c.815_818dup
NM_001270447.1:c.950_953dup
NM_001270448.1:c.653_656dup
NM_001033859.3:c.815_818dup
NM_001270447.2:c.950_953dup
NM_001270448.2:c.653_656dup

Likely Pathogenic

The Expert Panel has overridden the computationally generated classification - "Uncertain Significance - Insufficient Evidence"
Met criteria codes 2
PVS1 PM2_Supporting

Evidence Links 0

Expert Panel

Criteria Specification Information

Criteria Specifications for this VCEP
Evidence submitted by expert panel
ACADVL VCEP
The NM_000152.5: c.881_884dup (p.Pro296AlafsTer3) variant in ACADVL is a frameshift variant predicted to cause a premature stop codon in biologically relevant exon 10/20 leading to nonsense mediated decay in a gene in which loss-of-function is an established disease mechanism (PVS1). The highest population minor allele frequency in gnomAD v2.1.1 is 0.00009 in the Latino population, which is lower than the ClinGen ACADVL Variant Curation Expert Panel threshold (<0.001) for PM2_Supporting, meeting this criterion (PM2_Supporting). In summary, this variant meets the criteria to be classified as likely pathogenic for autosomal recessive very long chain acyl-CoA dehydrogenase (VLCAD) deficiency based on the ACMG/AMP criteria applied, as specified by the ClinGen ACADVL Variant Curation Expert Panel: PVS1, PM2_supporting. (ACADVL VCEP specifications version 1; approved February 28, 2023)
Met criteria codes
PVS1
frameshift in exon 10 of 20
PM2_Supporting
No code specific comments provided, please refer to the summary above or general recommendations provided in the guideline
Approved on: 2023-02-28
Published on: 2023-02-28
The information on this website is not intended for direct diagnostic use or medical decision-making without review by a genetics professional. Individuals should not change their health behavior solely on the basis of information contained on this website. If you have questions about the information contained on this website, please see a health care professional.
¤ Powered by BCM's Genboree.